Xopenex HFA Ready To Launch By Year-End
This article was originally published in The Pink Sheet Daily
You may also be interested in...
Sepracor COPD Treatment Approved
Brovana will be first-to-market long-acting bronchodilator developed in an inhalation solution for use with a nebulizer.
Sepracor COPD Treatment Approved
Brovana will be first-to-market long-acting bronchodilator developed in an inhalation solution for use with a nebulizer.
Sepracor Seeks FDA Nod For Long-Acting Beta Agonist Arformoterol
User fee date for the chronic obstructive pulmonary disease agent would fall in October, assuming a standard 10-month review.